Current Cancer Drug Targets

Editor-in-Chief:

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
USA

Back

Most Accessed Articles

P-glycoprotein Inhibition as a Therapeutic Approach for Overcoming Multidrug Resistance in Cancer: Current Status and Future Perspectives open access plus

Volume: 13   Issue: 3
Pp: 326-346
Ziyad Binkhathlan and Afsaneh Lavasanifar
DOI: 10.2174/15680096113139990076

Order Reprints Order Eprints

Multimodal HDAC Inhibitors with Improved Anticancer Activity promotion: free to download

Volume: 18   Issue: 1
Pp: 39-56
Rainer Schobert and Bernhard Biersack*
DOI: 10.2174/1568009617666170206102613

Order Reprints Order Eprints

Potential Anti-cancer Drugs Commonly Used for Other Indications promotion: free to download

Volume: 15   Issue: 1
Pp: 35-52
Veronika Hanusova, Lenka Skalova, Vera Kralova and Petra Matouskova
DOI: 10.2174/1568009615666141229152812

Order Reprints Order Eprints

A Comprehensive Outline of Trastuzumab Resistance Biomarkers in HER2 Overexpressing Breast Cancer open access plus

Volume: 15   Issue: 8
Pp: 665-683
Otília Menyhart, Libero Santarpia and Balazs Gyorffy
DOI: 10.2174/156800961508151001101742

Order Reprints Order Eprints

Lung Cancer Stem Cells: An Epigenetic Perspective promotion: free to download

Volume: 18   Issue: 1
Pp: 16-31
Samriddhi Shukla, Sajid Khan, Sonam Sinha and Syed Musthapa Meeran*
DOI: 10.2174/1568009617666170206104623

Order Reprints Order Eprints

Electrochemotherapy as First Line Cancer Treatment: Experiences from Veterinary Medicine in Developing Novel Protocols promotion: free to download

Volume: 16   Issue: 1
Pp: 43-52
E. P. Spugnini, T. Azzarito, S. Fais, M. Fanciulli and A. Baldi
DOI: 10.2174/156800961601151218155340

Order Reprints Order Eprints

MicroRNA Key to Angiogenesis Regulation: MiRNA Biology and Therapy

Volume: 18   Issue: 3
Pp: 266-277
Ankit Tiwari, Bratati Mukherjee and Manjusha Dixit*
DOI: 10.2174/1568009617666170630142725

Order Reprints Order Eprints

HR+, HER2– Advanced Breast Cancer and CDK4/6 Inhibitors: Mode of Action, Clinical Activity, and Safety Profiles open access plus

Volume: 17   Issue: 7
Pp: 637-649
Sarah L. Sammons, Donna L. Topping and Kimberly L. Blackwell*
DOI: 10.2174/1568009617666170330120452

Order Reprints Order Eprints